NCT01884337 - Multi-center Study to Evaluate the Safety of Apixaban (BMS-562247) in Indian Subjects Undergoing Elective Total Knee Replacement or Total Hip Replacement Surgery | Biotech Hunter

Enrollment

557

Participants

Timeline

Start Date

March 24, 2015

Primary Completion Date

June 4, 2018

Study Completion Date

June 4, 2018

Conditions

Anticoagulation

Interventions

DRUG

Apixaban

Trial Locations (20)

110029

Local Institution, Delhi

160012

Local Institution, Chandigarh

160062

Local Institution, Mohali

226003

Local Institution, Lucknow

380015

Local Institution, Ahmedabad

380016

Local Institution, Ahmedabad

380060

Local Institution, Ahmedabad

411001

Local Institution, Pune

411004

Local Institution, Pune

411005

Local Institution, Pune

411013

Local Institution, Pune

431003

Local Institution, Aurangabad

440003

Local Institution, Nagpur

500034

Local Institution, Hyderabad

560054

Local Institution, Bangalore

600010

Local Institution, Chennai

673008

Local Institution, Kozhikode

688005

Local Institution, Alappuzha

695011

Local Institution, Kerala

400 022

Local Institution, Mumbai